FUSIONTX Trademark

Trademark Overview

On Thursday, December 20, 2018, a trademark application was filed for FUSIONTX with the United States Patent and Trademark Office. The USPTO has given the FUSIONTX trademark a serial number of 88236893. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 1, 2022. This trademark is owned by HighTide Therapeutics USA. The FUSIONTX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of chronic diseases of the digestive system
fusiontx

General Information

Serial Number88236893
Word MarkFUSIONTX
Filing DateThursday, December 20, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 1, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 30, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of chronic diseases of the digestive system

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 17, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameHighTide Therapeutics USA
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressRockville, MD 20850
Party NameHighTide Therapeutics USA
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressRockville, MD 20850

Trademark Events

Event DateEvent Description
Monday, August 1, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 1, 2022ABANDONMENT - NO USE STATEMENT FILED
Wednesday, January 5, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 4, 2022SOU EXTENSION 5 GRANTED
Wednesday, December 22, 2021SOU EXTENSION 5 FILED
Monday, January 3, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 22, 2021TEAS EXTENSION RECEIVED
Friday, June 11, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 9, 2021SOU EXTENSION 4 GRANTED
Wednesday, June 9, 2021SOU EXTENSION 4 FILED
Wednesday, June 9, 2021TEAS EXTENSION RECEIVED
Wednesday, December 2, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 30, 2020SOU EXTENSION 3 GRANTED
Monday, November 30, 2020SOU EXTENSION 3 FILED
Monday, November 30, 2020TEAS EXTENSION RECEIVED
Saturday, June 13, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 11, 2020SOU EXTENSION 2 GRANTED
Thursday, June 11, 2020SOU EXTENSION 2 FILED
Thursday, June 11, 2020TEAS EXTENSION RECEIVED
Thursday, December 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 17, 2019SOU EXTENSION 1 GRANTED
Tuesday, December 17, 2019SOU EXTENSION 1 FILED
Tuesday, December 17, 2019TEAS EXTENSION RECEIVED
Tuesday, June 25, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 30, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 30, 2019PUBLISHED FOR OPPOSITION
Wednesday, April 10, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 18, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 15, 2019ASSIGNED TO EXAMINER
Thursday, January 17, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, December 24, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

fusiontx digestive system diseases chronic preparations treatment pharmaceutical